High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.

被引：0
|
作者：
Mitchell, SA
Bansi, D
Hunt, N
Christie, J
Fleming, K
Chapman, R
机构：
[1] JOHN RADCLIFFE HOSP, DEPT GASTROENTEROL, OXFORD OX3 9DU, ENGLAND
[2] JOHN RADCLIFFE HOSP, NUFFIELD DEPT PATHOL, OXFORD OX3 9DU, ENGLAND
来源：
GUT | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：TH115 / TH115
页数：1
相关论文
共 50 条
  • [21] Ursodeoxycholic acid (UDCA) and budesonide (BUD) in the treatment of primary biliary cirrhosis (PBC). A prospective double-blind trial.
    Leuschner, M
    Maier, KP
    Schlichting, J
    Strahl, R
    Herrmann, G
    Dahm, HH
    Ackermann, H
    Happ, J
    Leuschner, U
    HEPATOLOGY, 1999, 30 (04) : 471A - 471A
  • [22] High Dose Vitamin D on Interleukin-10 in Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial.
    FereshtehAshtari
    Nafisehtoghianifar
    SayyedhamidZarkesh-Esfahani
    MarjanMansourian
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 423 - 424
  • [23] Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease: A double-blind, randomized, placebo-controlled trial.
    Mendez-Sanchez, N
    Gonzalez, V
    Pichardo-Bahena, R
    Uribe, M
    HEPATOLOGY, 2002, 36 (04) : 412A - 412A
  • [24] A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
    Mitchell, SA
    Bansi, DS
    Hunt, N
    von Bergmann, K
    Fleming, KA
    Chapman, RW
    GASTROENTEROLOGY, 2001, 121 (04) : 900 - 907
  • [25] Ursodeoxycholic acid (UDC) and prednisolone in the treatment of primary biliary cirrhosis (PBC). Results of a controlled double-blind trial.
    Leuschner, M
    Guldutuna, S
    Hubner, K
    You, T
    Leuschner, U
    GASTROENTEROLOGY, 1996, 110 (04) : A1250 - A1250
  • [26] Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study
    Shaheen, N. J.
    Crockett, S. D.
    Bright, S. D.
    Madanick, R. D.
    Buckmire, R.
    Couch, M.
    Dellon, E. S.
    Galanko, J. A.
    Sharpless, G.
    Morgan, D. R.
    Spacek, M. B.
    Heidt-Davis, P.
    Henke, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 225 - 234
  • [27] Treatment with budesonide or prednisone in combination with ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): A randomized controlled pilot study.
    Vleggaar, FP
    van Hoogstraten, HJF
    Boland, GJ
    van Steenbergen, W
    van Hattum, J
    Henegouwen, GPV
    Schalm, SW
    van Buuren, HR
    HEPATOLOGY, 1998, 28 (04) : 647A - 647A
  • [28] Rituximab in rheumatoid arthritis: A double-blind, placebo-controlled, dose-ranging trial.
    Emery, P
    Fleischmann, RM
    Filipowicz-Sosnowska, A
    Schechtman, J
    Ramos-Remus, C
    Gomez-Reino, JJ
    Hessey, EW
    Shaw, TM
    Li, NF
    Agarwal, S
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S709 - S709
  • [29] A Multicentric, Double-Blind, Randomized Placebo-Controlled Trial of High Dose Ursodeoxycholic Acid in Patients with Non-Alcoholic Steatohepatitis (NASH)
    Ratziu, Vlad
    De Ledinghen, Victor
    Frederic, Oberti
    Mathurin, Philippe
    Bladou, Claire Wartelle
    Renou, Christophe
    Spenard, Jean
    GASTROENTEROLOGY, 2009, 136 (05) : A846 - A846
  • [30] URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS - RESULTS OF A CONTROLLED DOUBLE-BLIND TRIAL
    LEUSCHNER, U
    FISCHER, H
    KURTZ, W
    GULDUTUNA, S
    HUBNER, K
    HELLSTERN, A
    GATZEN, M
    LEUSCHNER, M
    GASTROENTEROLOGY, 1989, 97 (05) : 1268 - 1274
12345